<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0909245890
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2005
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        HARNAL 0.4MG MODIFIED RELEASE CAPSULES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TAMSULOSIN HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Modified-release capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        86.90
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G04CA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Harnal are modified release capsules. It contains Tamsulosin 0.4<br />mg in the capsules which is a so-called alpha-1a blocker that<br />reduces muscle contraction in the prostate and urethra. This<br />facilitates the flow of urine through the urethra and aids<br />urination.<br />Harnal are used for the treatment of urination symptoms caused<br />by benign prostatic hyperplasia )BPH - enlarged prostate(.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Harnal<br />If you are hypersensitive )allergic( to tamsulosin hydrochloride<br />or one of the product&rsquo;s other components. Hypersensitivity or<br />allergy to tamsulosin hydrochloride can express itself as sudden<br />swelling of hands or feet, difficulties in breathing and/or itch and<br />rash )angio-oedema(.<br />If you have experienced dizziness or have fainted from lowered<br />blood pressure )e.g. when suddenly sitting or standing up(.<br />If you have been found to suffer from severe liver problems.<br />Take special care with Harnal<br />&ndash; If you have been found to suffer from severe kidney problems.<br />&ndash; If you experience dizziness or fainting during the use of Harnal.<br />Please sit or lie down straight away until the symptoms<br />disappear.<br />&ndash; If you experience sudden swelling of hands or feet, difficulties<br />in breathing and/or itch and rash, caused by an allergic reaction<br />)angio-oedema( during the use of Harnal.<br />&ndash; If you have been scheduled for cataract surgery<br />Please consult your doctor, even if these statements were<br />applicable to you at any time in the past.<br />Taking other medicines<br />Tell your doctor or pharmacist if you are taking, have recently<br />taken or might take any other medicines.<br />This is because Harnal can affect the way that some other<br />medicines work and some other medicines can affect the way<br />that Harnal works.<br />In particular tell your doctor or pharmacist if you are taking:<br />&bull; Medicines to lower your blood pressure such as verapamil and<br />diltiazem<br />&bull; Medicines to treat HIV such as ritonavir or indinavir.<br />&bull; Medicines to treat a fungal infection such as ketaconazole or<br />itraconazole<br />&bull; Other alpha blockers such as doxazosin, indoramin, prazosin or<br />alfuzosin<br />&bull; Erythromycin, an antibiotic used to treat infections<br />Please inform your doctor that you are on Harnal before any<br />operation or dental procedure as there is a potential that your<br />medicine may interfere with the effects of the anaesthetic.<br />Harnal may lower blood pressure when taken with other alpha<br />1A-blockers.<br />Diclofenac )an anti-inflammatory painkiller( and warfarin )used<br />to prevent blood clotting( may have an influence on how fast<br />Harnal are removed from the body.<br />Please note that these statements may also apply to products<br />used some time ago or at some time in the future.<br />Please tell your doctor or pharmacist if you are taking, or have<br />recently taken, any other medicine, including medicines obtained<br />without prescription.<br />Taking Harnal with food and drink<br />Harnal should be taken after the first meal of the day. Taking<br />Harnal on an empty stomach may increase the number of side<br />effects or increase the severity of a side effect.<br />Pregnancy and breast-feeding<br />Harnal are intended for males only.<br />Ejaculation disorders have been observed.<br />Children and adolescents<br />Harnal are not indicated for use in the paediatric population<br />)patients below 18 years of age(.<br />Driving and using machines<br />Harnal can adversely affect the ability to drive or operate<br />machines. It should be taken into account that in some patients<br />dizziness may occur.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Harnal exactly as your doctor has told you. You<br />should check with your doctor or pharmacist if you are not sure.<br />The usual dose is one capsule a day after the first meal of the<br />day.<br />The capsule should be taken while standing or sitting upright<br />)not lying down( and should be swallowed whole with a glass of<br />water.<br />The capsule must not be chewed.<br />Your physician has prescribed a suitable dose for you and your<br />illness, and has specified the duration of the treatment.<br />The dose should not be independently changed.<br />If you have the impression that the effect of Harnal is too strong<br />or too weak, talk to your doctor or pharmacist.<br />If you take more Harnal than you should<br />If you may have taken more Harnal than you should, talk to your<br />doctor or pharmacist immediately.<br />If you forget to take Harnal<br />If you have forgotten to take Harnal after the first meal of the<br />day, it can be taken later the same day after food. If you have<br />missed a day, just continue to take your daily capsule as<br />prescribed.<br />Do not take a double dose to make up for forgotten individual<br />doses.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Harnal can cause side effects, although not<br />everybody gets them.<br />Common )may affect up to 1 in 10 people(:<br />&bull; dizziness, especially when you are getting up from a chair or<br />bed<br />&bull; ejaculation disorders<br />&bull; retrograde ejaculation )ejaculation into the bladder(<br />&bull; failure of ejaculation<br />Uncommon )may affect up to 1 in 100 people(:<br />&bull; headache<br />&bull; rapid heartbeat<br />&bull; dropping of blood pressure especially when standing up<br />&bull; blocked or runny nose<br />&bull; constipation<br />&bull; diarrhoea<br />&bull; nausea<br />&bull; vomiting<br />&bull; rash<br />&bull; nettle rash<br />&bull; itching<br />&bull; weakness<br />Rare )may affect up to 1 in 1,000 people(:<br />&bull; fainting<br />&bull; swelling of the lower layers of the skin, often around the mouth<br />or of the mucosa of the mouth or throat which can appear very<br />quickly<br />Very rare )may affect up to 1 in 10,000 people(:<br />&bull; priapism )painful, persistent, involuntary erection of the penis(,<br />in which case immediate medical aid is needed<br />&bull; a severe inflammatory eruption of the skin and mucous<br />membranes, which is an allergic reaction to drugs or other<br />substances called Stevens-Johnson syndrome<br />Not known )frequency cannot be estimated from the available<br />data(:<br />&bull; nose bleeding<br />&bull; vision blurred, visual impairment<br />&bull; dry mouth<br />&bull; serious skin rashes )erythema multiforme, dermatitis<br />exfoliative(<br />If you are undergoing eye surgery because of cloudiness of the<br />lens )cataract( and are already taking or have previously taken<br />tamsulosin hydrochloride, the pupil may dilate poorly and the iris<br />)the coloured circular part of the eye( may become floppy during<br />the procedure )see also section 2 &ldquo;Warnings and precautions&rdquo;(.<br />In addition to the adverse events listed above,<br />&bull; very rapid uncoordinated contractions of the heart<br />&bull; irregular rhythm of the heartbeat<br />&bull; abnormally rapid heart rate<br />&bull; difficulty in breathing<br />have been reported in association with Harnal use. Since these<br />spontaneously reported events are from worldwide postmarketing experience, the frequency of events and the role of<br />Harnal in these events cannot be reliably determined.<br />If any of the side effects gets serious, or if you notice any side<br />effects not listed in this leaflet, please tell your doctor or<br />pharmacist.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Store below 25 C&deg;<br />Do not use after the expiry date which is stated on the label and<br />carton after }EXP{. The expiry date refers to the last day of that<br />month.<br />Medicines should not be disposed of via wastewater or household<br />waste. Ask your pharmacist how to dispose of medicines no<br />longer required. These measures will help to protect the<br />environment.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; The active ingredient is Tamsulosin hydrochloride.<br />One modified-release capsule contains 0.4 mg of Tamsulosin<br />hydrochloride.<br />&bull; The other ingredients are Microcrystalline cellulose , Eudragit ,<br />Polysorbate , Sodium lauryl sulphate, Sodium lauryl sulphate,<br />Triacetin, Calcium Stearate, Talc and Empty gelatin capsule<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                HARNAL Capsules are Capsules with Olive Cap, Orange body and
contains pale yellowish white granules.
HARNAL Capsules are packed in aluminum blisters that are
supplied in a cardboard box. The packs contain 30 Capsules.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Saudi Arabian Japanese pharmaceutical company limited<br />Jeddah &ndash; Saudi Arabia<br />Under license from<br />ASTELLAS PHARMA INC<br />Tokyo-Japan<br />&nbsp;</p><p>-To report any side effect (s)<br />&bull; Saudi Arabia<br />- The National Pharmacovigilance Centre )NPC(:<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa<br />&bull; Other GCC States and other Countries:<br />- Please contact the relevant competent authority.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July /2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">هارنــال هــو كبســولات ممتــدة المفعــول. يحتــوي هارنــال علــى 0.4ملــج<br />تامســولوزين هيدروكلورايــد فــي كبســولات وهــو أحــد حاصــرات مســتقبلات<br />ألفــا الأدرينالينيــة مــن النــوع &quot;أ،&quot; والتــي ُتقلــل مــن انقبــاض العــضلات فــي<br />البروســتاتا ومجــرى البــول. ُيســهل ذلــك مــن مــرور البــول خلال مجــرى البــول،<br />كما ُيساعد في تسهيل عملية التبول.<br />ُيسـتخ َدم هارنـال لـعلاج أعـراض التبـول التـي تحـدث بسـبب َفرط َتن ُسـج البروسـتاتا<br />الحميد ( - BPHتضخم البروستاتا.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول هارنال في الحالات الآتية:<br />&bull; إذا كنــت تعانــي مــن فــرط الحساســية (الحساســية) تجــاه تامســولوزين<br />هيدروكلورايـد أو أ ٍي مـن المكونـات الأخـرى لهـذا الـدواءً. تظهـر أعـراض فـرط<br />الحساســية أو الحساســية تجــاه تامســولوزين هيدروكلورايــد فــي هيئــة تــورم<br />مفاجــئ فــي اليديــن أو القدميــن، صعوبــات فــي التنفــس و/ أو حكــة وطفــح<br />جلدي (وذمة وعائية.)<br />&bull;إذا عانيــت مــن حــدوث دوار، أو إغمــاءً؛ نتيجــة لانخفــاض ضغــط الــدم (علــى<br />سبيل المثال: عند الجلوس أو القيام بشكل مفاجئ.)<br />&bull; إذا ُو ِجد أنك تعاني من مشاكل شديدة بالكبد.<br />َ توخَّ حذ ًر ّ ا خاصّ ًة مع هارنال<br />&ndash; إذا ُو ِجد أنك تعاني من مشاكل شديدة بال ُكلى.<br />&ndash; إذا عانيـت مـن حـدوث دوار، أو إغمـاءً أثنـاءً اسـتخدام هارنـال. ُيرجـى الجلـوس<br />أو الاستلقاءً على الفور حتى تختفي الأعراض.<br />&ndash; إذا عانيــت مــن حــدوث تــورم بشــكل مفاجــئ فــي اليديــن أو القدميــن،<br />صعوبـات فـي التنفـس و/ أو حكـة وطفـح جلـدي نتيجـة لتفـاعلات الحساسـية<br />(الوذمة الوعائية) أثناءً استخدام هارنال.<br />&ndash; إذا كان من المقرر خضوعك لجراحة كاتاراكت بالعين (المياه البيضاءً.)<br />ُيرجـى استشـارة طبيبـك، حتـى إذا كان أ َي ممـا سـبق قـد انطبـق عليـك فـي أي<br />وقت مضى.<br />تنا ُول أدوية أخرى<br />أخبـر طبيبـك أو الصيدلـي إذا كنـت تتنـاول أو تناولـت مؤخـ ًرا أو قـد تتنـاول أي<br />أدوية أخرى.<br />وذلــك لأن هارنــال يمكــن أن يؤثــر علــى طريقــة عمــل بعــض الأدويــة الأخــرى،<br />وبعض الأدوية الأخرى يمكن أن تؤثر على طريقة عمل هارنال.<br />على وجه الخصوص، أخبر طبيبك أو الصيدلي إذا كنت تتناول:<br />&bull; أدوية لتخفيض ضغط الدم مثل فيراباميل وديلتيازيم<br />&bull; أدوية لعلاج فيروس نقص المناعة البشرية مثل ريتونافير أو إندينافير<br />&bull; أدوية لعلاج العدوى الفطرية مثل كيتوكونازول أو إيتراكونازول<br />&bull; حاصــرات ألفــا الأخــرى مثــل دوكسازوســين، إندوراميــن، برازوســين أو<br />ألفوزوسين<br />&bull; إريثرومايسين، مضاد حيوي يستخدم لعلاج العدوى<br />يرجـى إبلاغ طبيبـك بأنـك تتنـاول هارنـال قبـل أي عمليـة جراحيـة أو إجـراءً طـب<br />أسنان، حيث هناك احتمال أن يؤثر دوائك على تأثيرات التخدير.<br />قـد يخفـض هارنـال مـن ضغـط الـدم عنـد تنا ُولـه مـع حاصـرات مسـتقبلات ألفـا<br />الأدرينالينية من النوع &quot;أ&quot; الأخرى.<br />قــد ُيؤثــر كل مــن ديكلوفينــاك (دواءً مســكن ومضــاد للالتهــاب) ووارفاريــن<br />( ُيستخ َدم لمنع تجلط الدم) على مدى سرعة إزالة هارنال من الجسم.<br />ُيرجــى ملاحظــة أن هــذه البيانــات قــد تنطبــق علــى منتجــات دوائيــة قــد تــم<br />مـا<br />ٍت<br />اسـتخدامها لبعـض الوقـت فـي الماضـي، أو سـيتم اسـتخدامها فـي وقـ<br />في المستقبل.<br />ُيرجـى إبلاغ الطبيـب أو الصيدلـي ال َخـاص بـك إذا ُكنـت َتتنـاول أو تناولـت مؤخـ ًرا<br />أيــة أدويــة أخــرى، بمــا فيهــا الأدويــة التــي يتــ ّم الحصــول عليهــا دون وصفــة<br />ط ّبية.<br />َت َنا ُول هارنال مع الطعام والشراب<br />يجــب تنــا ُول هارنــال بعــد أول وجبــة فــي اليــوم. قــد يزيــد تنــا ُول هارنــال علــى<br />معدة خاوية من عدد الأعراض الجانبية أو شدة إحداها.<br />الحمل والرضاعة الطبيعية<br />هارنال ُمخصص للذكور فقط.<br />لوحظت اضطرابات القذف في بعض الحالات.<br />الأطفال والمراهقون:<br />هارنـال غيـر مخصـص للاسـتخدام فـي شـريحة الأطفـال (المرضـى أقـل مـن 18<br />عا ًما.)<br />القيادة واستخدام الآلات<br />يمكــن أن يؤثــر هارنــال بشــكل ســلبي علــى القــدرة علــى قيــادة أو تشــغيل<br />الآلات. يجب أن يؤخذ في الاعتبار أنه في بعض المرضى قد تحدث الدوخة<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تنــاول دائ ًمــا هارنــال كمــا أخبــرك طبيبــك بال َضبــط. إذا لــم تكــن متأكــ ًدا مــن<br />كيفية التناول، فيجب عليك مراجعة ال َطبيب أو الصيدلي الخاص بك.<br />الجرعة المعتادة هي كبسولة واحدة يوم ًيا بعد أول وجبة في اليوم.<br />يجـب تنـا ُول الكبسـولة أثنـاءً الوقـوف أو الجلـوس بشـكل مسـتقيم (وليـس فـي<br />وضع الاستلقاءً،) كما يجب ابتلاعها كاملة مع كوب من الماءً.<br />يجب عدم مضغ الكبسولة.<br />لقــد وصــف لــك طبيبــك الجرعــة المناســبة لــك ولحالتــك المرضيــة، كمــا حــدد<br />فترة العلاج.<br />لذا يجب عدم تغيير الجرعة من تلقاءً نفسك.<br />إذا كان لديـك انطبـاع بـأن تأثيـر هارنـال قـو ٌي جـ ًدا أو ضعيـ ٌف جـ ًدا، فتحـدث إلـى<br />الطبيب أو الصيدلي الخاص بك.<br />في حالة تنا ُول جرعة زائدة من هارنال<br />إذا كنــت قــد تناولــت جرعــة زائــدة مــن هارنــال، فتحــدث إلــى الطبيــب أو<br />الصيدلي الخاص بك على الفور.<br />إذا نسيت تنا ُول هارنال<br />إذا نسـيت تنـا ُول هارنـال بعـد أول وجبـة فـي اليـوم، فيمكـن تناولـه فـي وقـت<br />لاحــق مــن نفــس اليــوم بعــد الطعــام. إذا نســيت تنــا ُول الكبســولة فــي أحــد<br />الأيـام؛ فقـط اسـتمر فـي تنـا ُول الكبسـولات اليوميـة علـى النحـو الموصـوف<br />لك.<br />لا تتناول جرعة مضاعفة لتعويض الجرعات الفردية التي نسيتها<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثـل جميـع الأدويـة، ُيمكـن أن ُيسـبب هارنـال أعـراض جانبيـة، علـى الرغـم مـن<br />عدم حدوثها للجميع.<br />شائعة (قد يؤثر على شخص واحد من كل 10أشخاص<br />دوار خا ّص ًة عند الجلوس أو القيام<br />&bull; اضطرابات القذف<br />&bull; القذف إلى الوراءً (القذف في المثانة)<br />&bull; فشل القذف<br />غير شائع (قد يؤثر على شخص واحد من كل 100شخص:)<br />&bull; صداع الرأس<br />&bull; ضربات قلب سريعة<br />&bull; انخفاض ضغط الدم خاصة عند الوقوف<br />&bull; انسداد أو سيلان الأنف<br />&bull; الإمساك<br />&bull; إسهال<br />&bull; الغثيان<br />&bull; القيءً<br />&bull; طفح جلدي<br />&bull; لسع القراص<br />&bull; حكة<br />&bull; ضعف<br />نادر (قد يصل إلى 1من كل 1000شخص:)<br />&bull; الإغماءً<br />&bull; تــورم الطبقــات الســفلى مــن الجلــد، غال ًبــا حــول الفــم أو الغشــاءً المخاطــي<br />للفم أو الحنجرة التي يمكن أن تظهر بسرعة كبيرة<br />نادر ج ًدا (قد يؤثر على شخص واحد من بين كل 10000شخص:)<br />&bull;انتصاب مؤلم وممتد لفترات طويلة وغير مرغوب فيه ( ُقساح،)<br />&bull; التهــاب حــاد فــي الجلــد والأغشــية المخاطيــة، وهــو رد فعــل تحسســي<br />للأدوية أو مواد أخرى تسمى متلازمة ستيفنز جونسون.<br />آثـار جانبيـة ذات معـدلات حـدوث غيـر معروفـة: (لا يمكـن تقديـر التـردد مـن<br />البيانات المتاحة:)<br />&bull; نزيف الأنف<br />&bull; عدم وضوح الرؤية ، ضعف البصر<br />&bull; فم جاف<br />&bull; طفح جلدي خطير (حمامي عديدة الأشكال، التهاب الجلد التقشري)<br />إذا كنــت تخضــع لجراحــة العيــون بســبب غمامــة العدســة (الكاتاراكــت،) وقــد<br />أخــذت بالفعــل أو أخــذت مــن قبــل تامســولوزین ھیدروكلورایــد، فقــد يمتــد<br />الحدقـة بشـكل ضعيـف وقـد تصبـح القزحيـة (الجـزءً الدائـري الملـون مـن العيـن)<br />مر ًنا أثناءً العملية ( انظر أيضا القسم &quot; 2التحذيرات والاحتياطات.)&quot;<br />بالإضافة إلى الأحداث السلبية المذكورة أعلاه ،<br />&bull; تقلصات سريعة جدا غير منسقة للقلب<br />&bull; عدم انتظام ضربات القلب<br />&bull; معدل ضربات القلب غير طبيعي<br />&bull; صعوبة في التنفس<br />تم الإبلاغ عنها بالاشتراك مع استخدام هارنال:<br />بمـا أن هـذه الأحـداث التـي تـم الإبلاغ عنهـا بشـكل عفـوي هـي مـن تجربـة مـا<br />بعـد التسـويق فـي جميـع أنحـاءً العالـم ، فـإن تكـرار الأحـداث ودور هارنـال: فـي<br />هذه الأحداث لا يمكن تحديده بشكل موثوق به.<br />تمــت ملاحظــة احتماليــة حــدوث مضاعفــات متعلقــة بعمليــات إزالــة الميــاه<br />البيضاءً (كاتاراكت) في بعض الحالات.<br />إذا أصبــح أ ٌي مــن الأعــراض الجانبيــة خطيــ ًرا، أو إذا لاحظــت أيــة أعــراض جانبيــة<br />غير المدرجة في هذه النشرة، ُيرجى إبلاغ الطبيب أو الصيدلي الخاص بك<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعي ًدا عن ُمتناول ورؤية الأطفال.<br />ُيحفظ في درجة حرارة أقل من 25درجة مئوية.<br />لا تسـتخدم هارنـال بعـد انتهـاءً تاريـخ الصلاحيـة المـدون علـى ال ُملصـق والعبـوة<br />الكرتونيـة بعـد كلمـة &quot;ُ .&quot;EXPيشـير َتاريـخ انتهـاءً ال َصلاحيـة إلـى اليـوم الأخيـر مـن<br />ذلك ال َشهر.<br />يجـب عـدم ال َتخلـص مـن الأدويـة عـن طريـق إلقائهـا فـي ميـاه ال َصـرف أو مـع<br />المخلفـات المنزليـة. استفسـر مـن الصيدلـي الخـا ّص بـك عـن كيفيـة ال َتخلـص مـن<br />الأدويــة التــي لــم تعــد بحاجــة إليهــا. ستســاعد هــذه الإجــراءًات علــى حمايــة<br />البيئة<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المـادة الف َعالـة، تحتـوي الكبسـولة مديـدة المفعـول الواحـدة علـى 0.4ملـج<br />من تامسولوزين هيدروكلورايد<br />&bull; المكونــات الأخــرى هــي: ســليلوز فائــق التبلــور ، يودراجيــت، بوليســوربات،<br />لوريــل ســلفات الصوديــوم، ثلاثــي الأســيتين، ســتيرات الكالســيوم، بــودرة َتلــك<br />وكبسولة جيلاتينية فارغة<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كبسـولات هارنـال هـي كبسـولات ذات غطـاءً زيتونـي اللـون، وجسـم برتقالـي<br />اللون، وتحتوي على حبيبات ذات لون أصفر شاحب يميل إلى الأبيض.<br />تتــم تعبئــة كبســولات هارنــال فــي أشــرطة مــن الألومنيــوم داخــل عبــوة مــن<br />الكرتون ال ُمقوى. تحتوي العبوة على 30كبسولة<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة العربية السعودية اليابانية للمنتجات الصيدلانية المحدودة<br />جدة - المملكة العربية السعودية<br />بترخيص من<br />شركة استيلاس فارما المحدودة<br />طوكيو - اليابان<br />&nbsp;</p><p dir="RTL">للإبلاغ عن الأعراض الجانبية<br />&bull; المملكة العربية السعودية<br />- المركز الوطني للتيقظ والسلامة الدوائية<br />- مركز اتصالات الهيئة العامة للغذاءً والدواءً السعودية : 19999<br />npc.drug@sfda.gov.sa :- البريد الإلكتروني<br />https://ade.sfda.gov.sa :- الموقع الإلكتروني<br />&bull; دول الخليج الأخرى/ الدول الأخرى<br />- الرجاءً الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يوليو/2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tamsulosin 400 micrograms Modified-Release Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains 400 micrograms of tamsulosin hydrochloride. For a full list of
excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Modified-release capsule, hard Orange/olive-green capsule, with the black printed mark “SJ
0.4” The capsules contain white to off-white pellets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>One capsule a day after breakfast or the first meal of the day. The capsule is swallowed<br />whole with a glass of water while standing or sitting (not lying down). The capsule should<br />not be broken or pulled apart as this may have an effect on the release of the long-acting<br />active ingredient.<br />No dose adjustment is warranted in renal impairment. No dose adjustment is warranted in<br />patients with mild to moderate hepatic insufficiency (see also 4.3<br />Contraindications).<br />The safety and efficacy of tamsulosin in children &lt; 18 years have not been established.<br />Currently available data are described in section 5.1.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to tamsulosin, including drug-induced angio-oedema, or to any of the
excipients.
Orthostatic hypotension observed earlier (history of orthostatic hypotension).
Severe hepatic insufficiency.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other &alpha;1-adrenoceptor antagonists, a reduction in blood pressure can occur in individual cases during treatment with tamsulosin as a result of which, rarely, syncope can occur. At the first signs of orthostatic hypotension (dizziness, weakness), the patient should sit or lie down until the symptoms have disappeared.</p><p>Before therapy with tamsulosin is initiated, the patient should be examined in order to exclude the presence of other conditions, which can cause the same symptoms as benign prostatic hyperplasia.</p><p>Digital rectal examination and, when necessary, determination of prostate specific antigen (PSA) should be performed before treatment and at regular intervals afterwards.</p><p>The treatment of patients with severe renal impairment (creatinine clearance of &lt; 10 ml/min) should be approached with caution, as these patients have not been studied. Angio-oedema has been rarely reported after the use of tamsulosin. Treatment should be discontinued immediately, patient should be monitored until disappearance of the oedema, and tamsulosin should not be re-administered.</p><p>The &#39;Intraoperative Floppy Iris Syndrome&#39; (IFIS, a variant of small pupil syndrome) has been observed during cataract surgery in some patients on or previously treated with tamsulosin. IFIS may increase the risk of eye complications during and after the operation. The initiation of therapy with tamsulosin in patients for whom cataract surgery is scheduled is not recommended.</p><p>Discontinuing tamsulosin 1-2 weeks prior to cataract surgery is anecdotally considered helpful, but the benefit of treatment discontinuation has not yet been established. IFIS has also been</p><p>&nbsp;</p><p>reported in patients who had discontinued tamsulosin for a longer period prior to cataract surgery.</p><p>&nbsp;</p><p>&nbsp;</p><p>During pre-operative assessment, cataract surgeons and ophthalmic teams should consider whether patients scheduled for cataract surgery are being or have been treated with tamsulosin in order to ensure that appropriate measures will be in place to manage the IFIS during surgery.</p><p>Tamsulosin hydrochloride should not be given in combination with strong inhibitors of CYP3A4 in patients with poor metaboliser CYP2D6 phenotype.</p><p>Tamsulosin hydrochloride should be used with caution in combination with strong and moderate inhibitors of CYP3A4.</p><p>Tamsulosin is extensively metabolized, mainly by CYP3A4 and CYP2D6. (e.g., ketoconazole). (e.g., paroxetine) or moderate (e.g., terbinafine) inhibitors of CYP2D6, particularly at a dose higher than 0.4 mg (e.g., 0.8 mg). Drug capsules should be used with caution in combination with</p><p>cimetidine, particularly at a dose higher than 0.4 mg (e.g., 0.8 mg). Drug should not be used in combination with other alpha adrenergic blocking agents Caution is advised when alpha</p><p>adrenergic blocking agents including Tamsulosin hydrochloride are co-administered with PDE5 inhibitors. Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. Concomitant use of these two drug classes can potentially cause symptomatic hypotension</p><p>Caution should be exercised with concomitant administration of warfarin and Tamsulosin capsules</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interaction studies have only been performed in adults.</p><p>No interactions have been seen when tamsulosin was given concomitantly with either atenolol, enalapril, nifedipine or theophylline.</p><p>Concomitant cimetidine brings about a rise in plasma levels of tamsulosin, whereas furosemide a fall, but as levels remain within the normal range posology need not be adjusted. In vitro, neither diazepam nor propranolol, trichlormethiazide, chlormadinone, amitriptyline, diclofenac, glibenclamide, simvastatin and warfarin change the free fraction of tamsulosin in human plasma. Neither does tamsulosin change the free fractions of diazepam, propranolol, trichlormethiazide and chlormadinone.</p><p>Diclofenac and warfarin, however, may increase the elimination rate of tamsulosin.</p><p><em>Strong and Moderate Inhibitors of CYP3A4 or CYP2D6</em></p><p>Tamsulosin is extensively metabolized, mainly by CYP3A4 and CYP2D6.</p><p>Concomitant treatment with ketoconazole (a strong inhibitor of CYP3A4) resulted in an increase in the Cmax and AUC of tamsulosin by a factor of 2.2 and 2.8, respectively. The effects of concomitant administration of a moderate CYP3A4 inhibitor (e.g., erythromycin) on the pharmacokinetics of Tamsulosin have not been evaluated</p><p>Concomitant treatment with paroxetine (a strong inhibitor of CYP2D6) resulted in an increase in the Cmax and AUC of tamsulosin by a factor of 1.3 and 1.6, respectively. A similar increase in</p><p>exposure is expected in CYP2D6 poor metabolizers (PM) as compared to extensive metabolizers (EM). Since CYP2D6 PMs cannot be readily identified and the potential for significant increase in tamsulosin exposure exists when Tamsulosin is co-administered with strong CYP3A4 inhibitors in CYP2D6 PMs, Tamsulosin should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole)</p><p>&nbsp;</p><p>The effects of concomitant administration of a moderate CYP2D6 inhibitor (e.g., terbinafine) on the pharmacokinetics of Tamsulosin have not been evaluated</p><p>The effects of co-administration of both a CYP3A4 and a CYP2D6 inhibitor with Tamsulosin capsules have not been evaluated. However, there is a potential for significant increase in tamsulosin exposure when Tamsulosin is co-administered with a combination of both CYP3A4 and CYP2D6 inhibitors</p><p>Cimetidine: Treatment with cimetidine resulted in a significant decrease (26%) in the clearance of tamsulosin hydrochloride, which resulted in a moderate increase in tamsulosin hydrochloride AUC (44%)</p><p>Tamsulosin hydrochloride should not be given in combination with strong inhibitors of CYP3A4 in patients with poor metaboliser CYP2D6 phenotype.</p><p>Tamsulosin hydrochloride should be used with caution in combination with strong and moderate inhibitors of CYP3A4.</p><p>Concurrent administration of other &alpha;1-adrenoceptor antagonists could lead to hypotensive effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tamsulosin is intended for males only.<br />Ejaculation disorders have been observed in short and long term clinical studies with<br />tamsulosin. Events of ejaculation disorder, retrograde ejaculation and ejaculation failure<br />have been reported in the post authorization phase.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.<br />However patients should be aware of the fact that dizziness can occur.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>a) Summary of safety</strong><br />Not Applicable<br /><strong>b) Tabulated adverse reactions</strong><br /><img alt="" width="715" height="590" src="data:image/png;base64,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" /></p><p><strong>c) Description of selected adverse events:</strong><br />During cataract surgery a small pupil situation, known as Intraoperative Floppy Iris Syndrome<br />(IFIS), has been associated with therapy of tamsulosin during post-marketing surveillance<br /><strong>d) Pediatric use:</strong><br />Not applicable<br /><strong>e) Other special population:</strong><br /><strong>Renal Patients:</strong><br />The treatment of severely renally impaired patients (creatinine clearance of &lt; 10 ml/min)<br />should be approached with caution as these patients havenot been studied.<br /><strong>IFIS:</strong><br />The &#39;Intraoperative Floppy Iris Syndrome&#39; (IFIS, a variant of small pupil syndrome) has been<br />observed during cataract surgery in some patients on or previously treated with tamsulosin.<br />IFIS may lead to increased procedural complications during the operation. The initiation of<br />therapy with tamsulosin in patients for whom cataract surgery is scheduled is not<br />recommended.<br />&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>Saudi Arabia</strong></p><p>&nbsp;</p><p>The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp; SFDA Call Center: 19999</p><p>-&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p>Other GCC States</p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute overdose with 5 mg tamsulosin hydrochloride has been reported. Acute hypotension<br />(systolic blood pressure 70 mm Hg), vomiting and diarrhoea were observed, which were<br />treated with fluid replacement and the patient could be discharged the same day. In case of<br />acute hypotension occurring after overdosage cardiovascular support should be given. Blood<br />pressure can be restored and heart rate brought back to normal by lying the patient down. If<br />this does not help then volume expanders and, when necessary, vasopressors could be<br />employed. Renal function should be monitored and general supportive measures applied.<br />Dialysis is unlikely to be of help as tamsulosin is very highly bound to plasma proteins.<br />Measures, such as emesis, can be taken to impede absorption if large quantities of the medicinal<br />product are involved, gastric lavage may be performed and activated charcoal and an osmotic<br />laxative, such as sodium sulphate, may be given.<br />&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: &alpha;1A adrenoreceptor antagonist. ATC code: G04CA02 Mechanism<br />of action Tamsulosin binds selectively and competitively to postsynaptic &alpha;1A adrenoreceptors,<br />which convey smooth muscle contraction, thereby relaxing prostatic and urethral smooth<br />muscle.<br />o Please contact the relevant competent authority.<br />Pharmacodynamic effects<br />Tamsulosin increases the maximum urinary flow rate by relaxing prostatic and urethral smooth<br />muscle, thus relieving obstruction.<br />The medicinal product also improves the irritative and obstructive symptoms in which the<br />contraction of smooth muscle in the lower urinary tract plays an important role.<br />Alpha-blockers can reduce blood pressure by lowering peripheral resistance. No reduction in<br />blood pressure of any clinical significance was observed during studies with tamsulosin in<br />normotensive patients.<br />The medicinal product&#39;s effect on storage and voiding symptoms are also maintained during<br />long-term therapy, as a result of which the need for surgical treatment is significantly<br />postponed.<br />Paediatric population<br />A double-blind, randomized, placebo-controlled, dose ranging study was performed in<br />children with neuropathic bladder. A total of 161 children (with an age of 2 to 16 years) were<br />randomized and treated at 1 of 3 dose levels of tamsulosin (low [0.001 to 0.002 mg/kg],<br />medium [0.002 to 0.004 mg/kg], and high [0.004 to 0.008 mg/kg]), or placebo. The primary<br />endpoint was number of patients who decreased their detrusor leak point pressure (LPP) to<br />&lt;40 cm H2O based upon two evaluations on the same day. Secondary endpoints were:<br />Actual and percent change from baseline in detrusor leak point pressure, improvement or<br />stabilization of hydronephrosis and<br />hydroureter and change in urine volumes obtained by catheterisation and number of times<br />wet at time of catheterisation as recorded in catheterisation diaries. No statistically<br />significant difference was found between the placebo group and any of the 3 tamsulosin<br />dose groups for either the primary or any secondary endpoints. No dose response was<br />observed for any dose level.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong><br />Tamsulosin is rapidly absorbed from the intestines and its bioavailability is almost complete.<br />Absorption is slowed down if a meal has been eaten before taking the medicinal product.<br />Uniformity of absorption can be assured by always taking tamsulosin after breakfast.<br />Tamsulosin shows linear kinetics.<br />Peak plasma levels are achieved at approximately six hours after a single dose of tamsulosin<br />taken after a full meal. The steady state is reached by day five of multiple dosing, when<br />Cmax in patients is about two-thirds higher than that reached after a single dose. Although<br />this has been demonstrated only in the elderly, the same result would also be expected in<br />youngerpatients.<br />There are huge inter-patient variations in plasma levels of tamsulosin, both after single as<br />well as multiple dosing.<br /><strong>Distribution</strong><br />In humans, tamsulosin is more than 99% bound to plasma proteins and the volume of<br />distribution is small (about 0.2 l/kg).<br /><strong>Biotransformation</strong><br />Tamsulosin has a low first pass metabolic effect. Most tamsulosin is found unaltered in<br />plasma. The substance is metabolised in the liver.<br />In studies on rats, tamsulosin was found to cause only a slight induction of microsomal liver<br />enzymes.<br />The metabolites are not as effective and toxic as the active medicinal product itself.<br /><strong>Excretion</strong><br />Tamsulosin and its metabolites are mainly excreted in the urine with about 9% of the dose<br />being present in unchanged form.<br />The elimination half-life of tamsulosin in patients is approximately 10 hours (when taken<br />after a meal) and 13 hours in the steady state.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Toxicity after a single dose and multiple dosing has been investigated in mice, rats and<br />dogs. Reproductive toxicity has also been investigated in rats, carcinogenicity in mice and<br />rats, and genotoxicity in vivo and in vitro.<br />The common toxicity profile found with large doses of tamsulosin is equivalent to the<br />pharmacological effect associated with alpha adrenergic antagonists.<br />Changes in ECG readings were found with very large doses in dogs. This is not, however,<br />assumed to be of any clinical significance. Tamsulosin has not been found to have any<br />significant genotoxic properties.<br />Greater proliferative changes in the mammary glands of female rats and mice have been<br />discovered on exposure to tamsulosin. These findings, which are probably indirectly linked<br />to hyperprolactinaemia and only occur as a result of large doses having been taken, are<br />considered clinically insignificant.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose (Avicel PH101), Eudragit L30D-55, Polysorbate 80,<br />Sodium lauryl sulphate, Triacetin, Calcium Stearate, Talc<br />Empty gelatin capsule<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg; C.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium / aluminium foil blister packs containing 30 Capsules<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Saudi Arabian Japanese pharmaceutical company limited
Jeddah – Saudi Arabia
Under license from ASTELLAS PHARMA INC Tokyo-Japan
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>